Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project.

2.50
Hdl Handle:
http://hdl.handle.net/10541/620566
Title:
Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project.
Authors:
Bubendorf, L; Dafni, U; Schöbel, M; Finn, S; Tischler, V; Sejda, A; Marchetti, A; Thunnissen, E; Verbeken, E; Warth, A; Sansano, I; Cheney, R; Speel, E; Nonaka, Daisuke ( 0000-0003-4027-5116 ) ; Monkhorst, K; Hager, H; Martorell, M; Savic, S; Kerr, K; Tan, Q; Tsourti, Z; Geiger, T; Kammler, R; Schulze, K; Das-Gupta, A; Shames, D; Peters, S; Stahel, R
Abstract:
In a well-defined NSCLC cohort of the ETOP Lungscape program, we explored the epidemiology of IHC MET overexpression and amplification, their inter-correlation, and their association to outcome.
Affiliation:
Institute of Pathology, University Hospital Basel, Basel, Switzerland
Citation:
Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. 2017, 111:143-149 Lung Cancer
Journal:
Lung Cancer
Issue Date:
Sep-2017
URI:
http://hdl.handle.net/10541/620566
DOI:
10.1016/j.lungcan.2017.07.021
PubMed ID:
28838386
Type:
Article
Language:
en
ISSN:
1872-8332
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorBubendorf, Len
dc.contributor.authorDafni, Uen
dc.contributor.authorSchöbel, Men
dc.contributor.authorFinn, Sen
dc.contributor.authorTischler, Ven
dc.contributor.authorSejda, Aen
dc.contributor.authorMarchetti, Aen
dc.contributor.authorThunnissen, Een
dc.contributor.authorVerbeken, Een
dc.contributor.authorWarth, Aen
dc.contributor.authorSansano, Ien
dc.contributor.authorCheney, Ren
dc.contributor.authorSpeel, Een
dc.contributor.authorNonaka, Daisukeen
dc.contributor.authorMonkhorst, Ken
dc.contributor.authorHager, Hen
dc.contributor.authorMartorell, Men
dc.contributor.authorSavic, Sen
dc.contributor.authorKerr, Ken
dc.contributor.authorTan, Qen
dc.contributor.authorTsourti, Zen
dc.contributor.authorGeiger, Ten
dc.contributor.authorKammler, Ren
dc.contributor.authorSchulze, Ken
dc.contributor.authorDas-Gupta, Aen
dc.contributor.authorShames, Den
dc.contributor.authorPeters, Sen
dc.contributor.authorStahel, Ren
dc.date.accessioned2017-09-22T15:36:47Z-
dc.date.available2017-09-22T15:36:47Z-
dc.date.issued2017-09-
dc.identifier.citationPrevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. 2017, 111:143-149 Lung Canceren
dc.identifier.issn1872-8332-
dc.identifier.pmid28838386-
dc.identifier.doi10.1016/j.lungcan.2017.07.021-
dc.identifier.urihttp://hdl.handle.net/10541/620566-
dc.description.abstractIn a well-defined NSCLC cohort of the ETOP Lungscape program, we explored the epidemiology of IHC MET overexpression and amplification, their inter-correlation, and their association to outcome.en
dc.language.isoenen
dc.rightsArchived with thanks to Lung cancer (Amsterdam, Netherlands)en
dc.titlePrevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project.en
dc.typeArticleen
dc.contributor.departmentInstitute of Pathology, University Hospital Basel, Basel, Switzerlanden
dc.identifier.journalLung Canceren

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.